Atomwise

At Atomwise, we invented the first deep learning neural networks for structure-based small molecule drug discovery and we’re currently deploying it in one of the largest applications of machine learning for life sciences. We work on Alzheimer’s, cancer, diabetes, drug-resistant antibiotics, safe pesticides, among treatments for other diseases. We’ve partnered with 4 of the top-10 US pharma companies, raised over $170M from top VCs, and have 100+ diverse projects currently running. We were recently awarded Fast Company's top 10 most innovative companies in the Biotechnology category.